Wang B, Pan J, Zhang T, Ni X, et al. Protocol for CHAMPION study: a prospective study of maximal-cytoreductive therapies for patients with de novo metastatic hormone-sensitive prostate cancer who achieve oligopersistent metastases during systemic treatment with apalutamide plus androgen BMC Cancer 2024;24:643.
PMID: 38796422